NuCana
Utility Patent Applications

Last updated:

List of all NuCana patents 22 in total

Status Patent
Application
Utility: FORMULATION COMPRISING A GEMCITABINE-PRODRUG External link
Filling date: 7 Sep 2025 Issue date: 3 Feb 2022
Application
Utility: PROCESS FOR PREPARING NUCLEOSIDE PRODRUGS External link
Filling date: 7 Sep 2025 Issue date: 3 Feb 2022
Application
Utility: FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS External link
Filling date: 7 Sep 2025 Issue date: 3 Feb 2022
Application
Utility: SALT OF TRIPHOSPHATE PHOSPHORAMIDATES OF NUCLEOTIDES AS ANTICANCER COMPOUNDS External link
Filling date: 7 Sep 2025 Issue date: 27 Jan 2022
Application
Utility: PHOSPHORAMIDATE DERIVATIVES OF 5 - FLUORO - 2` - DEOXYURIDINE FOR USE IN THE TREATMENT OF CANCER External link
Filling date: 7 Sep 2025 Issue date: 27 Jan 2022
Application
Utility: CRYSTALLINE FORM OF GEMCITABINE External link
Filling date: 7 Sep 2025 Issue date: 24 Jun 2021
Application
Utility: SALTS OF DIPHOSPHATE PHOSPHORAMIDATE OF NUCLEOSIDES AS ANTICANCER COMPOUNDS External link
Filling date: 7 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS External link
Filling date: 7 Sep 2025 Issue date: 6 May 2021
Application
Utility: CANCER TREATMENTS BASED ON GEMCITABINE PRODRUGS External link
Filling date: 7 Sep 2025 Issue date: 8 Apr 2021
Application
Utility: DIASTEREOSELECTIVE SYNTHESIS OF PHOSPHATE DERIVATIVES External link
Filling date: 7 Sep 2025 Issue date: 14 Jan 2021
Application
Utility: FORMULATION COMPRISING A GEMCITABINE-PRODRUG External link
Filling date: 7 Sep 2025 Issue date: 24 Dec 2020
Application
Utility: Treatment Regimens External link
Filling date: 7 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: COMBINATION THERAPY FOR CANCER External link
Filling date: 7 Sep 2025 Issue date: 27 Aug 2020
Application
Utility: GEMCITABINE PRODRUGS External link
Filling date: 7 Sep 2025 Issue date: 20 Aug 2020
Application
Utility: FLOXURIDINE SYNTHESIS External link
Filling date: 7 Sep 2025 Issue date: 20 Aug 2020
Application
Utility: Combination Therapy External link
Filling date: 7 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: 2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DERIVATIVES AS ANTI-CANCER COMPOUNDS External link
Filling date: 7 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: SYNTHESIS OF 3'-DEOXYADENOSINE-5'-O-[PHENYL(BENZYLOXY-L-ALANINYL)]PHOSPHATE (NUC-7738) External link
Filling date: 7 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: SYNTHESIS OF PHOSPHATE DERIVATIVES External link
Filling date: 7 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS External link
Filling date: 7 Sep 2025 Issue date: 12 Dec 2019
Application
Utility: ADENOSINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER External link
Filling date: 7 Sep 2025 Issue date: 12 Dec 2019
Application
Utility: CANCER TREATMENTS External link
Filling date: 7 Sep 2025 Issue date: 12 Dec 2019

Showing 1 to 22 of 22 patents.